Tyrosine kinase inhibitors (TKIs) are a class of pharmacological agents that block the action of tyrosine kinases. These enzymes catalyze the transfer of a phosphate group from ATP to a tyrosine residue in a protein, a crucial step in many cellular signaling pathways. TKIs are predominantly used in cancer therapy as they can prevent the proliferation of cancer cells by inhibiting these signaling pathways.
